HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Topical retinaldehyde treatment in oral lichen planus and leukoplakia.

Abstract
The aim of this exploratory study was to assess the efficacy of a natural metabolite of vitamin A, retinaldehyde 0.1%, vehicled in a gel in 17 patients with oral lichen planus and in 13 patients with oral leukoplakia, twice daily for 2 months. Our investigation was clinical, histological, immunohistochemical through the expression of markers of cell terminal differentiation and biochemical by using two-dimensional gel electrophoresis of cytokeratins (CK). In addition, the activity of retinaldehyde was studied ex vivo on surviving buccal mucosa. Retinaldehyde gel 0.1% showed good clinical efficacy, resulting in 6% disappearance and 82% improvement of the lesions in lichen planus and 17% disappearance and 75% improvement in leukoplakia. This was confirmed with immunohistochemistry, which revealed down-regulation of filaggrin and CK-10 as markers of terminal differentiation in both diseases. The effects of retinaldehyde in these two diseases were further demonstrated in the ex vivo surviving mucosal model, resulting in histological disappearance of keratinization in 80% of the lichen planus fragments and 40% of the leukoplakia fragments, associated with down-regulation of filaggrin and CK-10.
AuthorsS Boisnic, D Licu, L Ben Slama, M C Branchet-Gumila, H Szpirglas, P Dupuy
JournalInternational journal of tissue reactions (Int J Tissue React) Vol. 24 Issue 4 Pg. 123-30 ( 2002) ISSN: 0250-0868 [Print] Switzerland
PMID12779246 (Publication Type: Journal Article)
Chemical References
  • FLG protein, human
  • Filaggrin Proteins
  • Intermediate Filament Proteins
  • Keratins
  • Retinaldehyde
Topics
  • Administration, Topical
  • Adult
  • Aged
  • Aged, 80 and over
  • Biopsy
  • Female
  • Filaggrin Proteins
  • Humans
  • Intermediate Filament Proteins (metabolism)
  • Keratins (metabolism)
  • Leukoplakia, Oral (drug therapy, pathology)
  • Lichen Planus, Oral (drug therapy, pathology)
  • Male
  • Middle Aged
  • Retinaldehyde (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: